Is acquired activated protein C resistance a cardiovascular risk?

K. Kario, T. Sakata, T. Miyata, S. Kiechl, J. Willeit

Icahn School of Medicine at Mount Sinai

Research output: Contribution to journal › Comment/debate

3 Scopus citations

Original language	English
Pages (from-to)	E120
Journal	Circulation
Volume	101
Issue number	12
DOIs	https://doi.org/10.1161/01.cir.101.12.e120
State	Published - 28 Mar 2000

Access to Document

10.1161/01.cir.101.12.e120

Cite this

@article{16a6eaff3d6647ae8368776577fa71ab,

title = "Is acquired activated protein C resistance a cardiovascular risk?",

author = "K. Kario and T. Sakata and T. Miyata and S. Kiechl and J. Willeit",

year = "2000",

month = mar,

day = "28",

doi = "10.1161/01.cir.101.12.e120",

language = "English",

volume = "101",

pages = "E120",

journal = "Circulation",

issn = "0009-7322",

publisher = "Lippincott Williams and Wilkins Ltd.",

number = "12",

}

TY - JOUR

T1 - Is acquired activated protein C resistance a cardiovascular risk?

AU - Kario, K.

AU - Sakata, T.

AU - Miyata, T.

AU - Kiechl, S.

AU - Willeit, J.

PY - 2000/3/28

Y1 - 2000/3/28

UR - http://www.scopus.com/inward/record.url?scp=0034724097&partnerID=8YFLogxK

U2 - 10.1161/01.cir.101.12.e120

DO - 10.1161/01.cir.101.12.e120

M3 - Comment/debate

C2 - 10736301

AN - SCOPUS:0034724097

SN - 0009-7322

VL - 101

SP - E120

JO - Circulation

JF - Circulation

IS - 12

ER -